Eastman Chemical (EMN) EBITDA (2009 - 2026)

Eastman Chemical (EMN) has reported EBITDA for 18 consecutive years, with $309.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA rose 14.87% year-over-year to $309.0 million; the trailing twelve-month figure through Jun 2026 stood at $750.0 million (down 37.55% YoY), and the FY2025 full-year result was $835.0 million, down 33.36% from the prior year.
• EBITDA climbed to $309.0 million in Q2 2026 per EMN's latest filing, from $184.0 million in the prior quarter.
• Across five years, EBITDA topped out at $399.0 million in Q2 2022 and bottomed at $67.0 million in Q4 2025.
• Historically, EBITDA has averaged $263.0 million across 5 years, with a median of $279.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: EBITDA jumped 81.08% in 2023, then tumbled 77.36% in 2025.
• Over 5 years, EBITDA stood at $111.0 million in 2022, then surged by 81.08% to $201.0 million in 2023, then soared by 47.26% to $296.0 million in 2024, then sank by 77.36% to $67.0 million in 2025, then jumped by 361.19% to $309.0 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $309.0 million, $184.0 million, and $67.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.